EMA implements new measures to minimise animal testing during medicines development
EMA is putting in place special support to developers to replace, reduce and refine animal use for the development, manufacturing and testing of human and veterinary medicines. The Agency is promoting these three principles - replace, reduce and refine; commonly referred to as 3Rs - through EMA's Innovation Task Force (ITF). This action will facilitate the development and implementation of New Approach Methodologies (NAMs) that are in line with the European Union legislation on the protection of animals used for scientific purposes.
For more information see the EMA Website.